首页> 外国专利> Compound, polypeptide, nucleic acid, vector, recombinant defective virus, antibody or antibody fragment or derivative, pharmaceutical composition, processes for the selection or characterization of active molecules and for the production of a peptide compound, protein, cell, and mammal not human

Compound, polypeptide, nucleic acid, vector, recombinant defective virus, antibody or antibody fragment or derivative, pharmaceutical composition, processes for the selection or characterization of active molecules and for the production of a peptide compound, protein, cell, and mammal not human

机译:化合物,多肽,核酸,载体,重组缺陷病毒,抗体或抗体片段或衍生物,药物组合物,用于选择或表征活性分子以及生产非人类的肽化合物,蛋白质,细胞和哺乳动物的方法

摘要

"COMPOSITE, POLYPEPTIDE, NUCLEIC ACID, VECTOR, DEFECTIVE RECOMBINANT VIRUS, ANTIBODY OR ANTIBODY DERIVATIVE, PHARMACEUTICAL COMPOSITION, PROCESSES FOR THE SELECTION OR CHARACTERIZATION OF A PRODUCE, MOLDLE PRODUCT, CELL PRODUCT, Non-Human Mammal ". The present invention relates to novel compounds and their uses, mainly pharmaceutical, diagnostic or as pharmacological targets. More particularly, the present invention relates to a novel protein called PAP1, and also to novel peptides and compounds capable of at least partially modulating parkin activity.
机译:“复合,多肽,核酸,载体,缺陷型重组病毒,抗体或抗体衍生物,药物成分,选择或表征产品,模具产品,细胞产品,非人类哺乳动物的过程。”本发明涉及新颖的化合物及其用途,主要是药物,诊断或作为药理学靶标。更具体地,本发明涉及一种称为PAP1的新型蛋白质,并且还涉及能够至少部分地调节parkin活性的新型肽和化合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号